SecBot SecBot
8-K ·Filed Oct 1, 2026

CNBX

CNBX Pharmaceuticals Inc.
BEARISH
Impact 5/10
Horizonweeks Processed26d 7h ago SEC0001683168-26-007522
8-K material event: Items 4.01
Actionable Insight ▼ Bearish

Monitor for any subsequent 8-K filings under Item 4.02 (non-reliance) or Item 2.05 (restructuring), which would confirm the auditor change was a precursor to financial problems. The switch to a small foreign auditor often precedes accounting issues or a lack of available Big 4 firms willing to take the engagement.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+5d
CNBX ▲ +100.00% at T+5d
SHORT call ✗ call lost -100.00% · α vs SPY -98.70% · entry $0.000100 → $0.000200
Next anchor: T+20d tomorrow
Latest observation: T+16 +3.63% FF3 residual α
Entry = T+0 close
Oct 1, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.74%
$0.000100
settled 26d ago
T+5d
+100.00%
call -100.00% · α -98.70%
$0.000200
settled 20d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

CNBX Pharmaceuticals dismissed its auditor, Elkana Amitai CPA, and hired Vilki & Co., a firm based in Gujarat, India, effective September 28, 2026. The filing states no disagreements or reportable events occurred with the former auditor, but the change to a smaller, non-Big 4 firm is a red flag, especially given the prior going-concern qualification.

Key Facts

  • Former auditor Elkana Amitai CPA was dismissed effective September 28, 2026.
  • New auditor is Vilki & Co., based in Gujarat, India.
  • No disagreements or reportable events were reported with the former auditor.
  • The former auditor's reports for fiscal years 2024 and 2025 included a going-concern explanatory paragraph.
  • The change was not the result of any disagreement with the former accounting firm.

Financial Impact

Auditor change to a smaller, India-based firm is a governance red flag; going-concern doubt persists.

auditor qualitygoing concern

Risk Factors

  • Potential undisclosed accounting issues or disagreements that may surface later.
  • Increased risk of financial restatement or delayed filings.
  • Going-concern risk remains elevated as noted in prior audit reports.

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001683168-26-007522
Document: cnbx_ex1601.htm0001683168-26-007522
Document: 0001683168-26-007522-index-headers.html0001683168-26-007522
Document: 0001683168-26-007522-index.html0001683168-26-007522
Document: 0001683168-26-007522.txt0001683168-26-007522

US Market Status

Market Closed — Opens Thu (11h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 1, 2026